Xstrahl is pleased to be invited as a sponsor for BACR Tumour Microenvironment: Basic Science to Novel Therapies conference and BACR 3D Models Workshop taking place on 14 - 16 June in Nottingham, UK. The conference will cover a wide number of topics with sessions on...
ESTRO 36 in Vienna, Austria saw Xstrahl Medical and Life Sciences come together to display some of the advances in radiotherapy solutions over the last year between the 5th and 9th of May 2017.
The SARRP User Spring Symposium event gathers together thought leaders, scholars and operators of Xstrahl Small Animal Radiation Research (SARRP) systems from all over the world.
BACKGROUND: To develop a new molecular targeted treatment for brain (AVMs), identification of membrane proteins that are localised on the AVM endothelium is crucial. Current treatment methods are surgery and radiosurgery. However, complete occlusion post radiosurgery...
Modulation of the redox system in cancer cells has been considered a promising target for anti-cancer therapy. The novel MTH1 inhibitor TH588 proved tremendous potential in terms of cancer cell eradication, yet its specificity has been questioned by recent reports,...
For decades, low- and moderate-dose radiation therapy (RT) has been shown to exert a beneficial therapeutic effect in a multitude of non-malignant conditions including painful degenerative muscoloskeletal and hyperproliferative disorders. Dupuytren and Ledderhose...
PURPOSE: Melanoma is mainly treated by surgery and rarely with radiation because of the high radioresistance of this tumor. Nevertheless, radiotherapy is the preferred treatment modality for unresectable lesions and avoiding cosmetic disfigurement caused by surgical...
Introduction Preclinical CT-guided radiotherapy platforms are increasingly used but the CT images are characterized by poor soft tissue contrast. The aim of this study was to develop a robust and accurate method of MRI-guided radiotherapy (MR-IGRT) delivery to...
April 5th, 2017 – Xstrahl is pleased to announce the supply of the first superficial radiotherapy system – Xstrahl 200 to Havana, Cuba. The equipment was installed in early 2016 and has now been successfully treating Cuban cancer patients for the last 12 months....
Contact Us